MWA
NBP

Marshall Wace Asia’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Marshall Wace Asia’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-44,893
Closed -$3.77M – 157
2021
Q2 		$3.77M Buy
+44,893
New +$2.96M 0.08% 89

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CC
Cederberg Capital London, United Kingdom $100M AUM 90.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ZAM
Zeal Asset Management Central, Hong Kong $39.4M AUM 38.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Marshall Wace Asia's NBP Position: Q3 2021 in Review

Marshall Wace Asia sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q3 2021, closing a stake of 44,893 shares — an estimated $3.77M sold.

Marshall Wace Asia first reported a position in NBP in Q2 2021 and held it in 1 quarter. The position peaked at $3.77M in Q2 2021. 144 funds tracked by Wall St. Rank hold NBP as of Q3 2021.

  • Marshall Wace Asia reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q3 2021 after selling out during the quarter.
  • Marshall Wace Asia sold 44,893 NovaBridge Biosciences American Depositary Shares shares in Q3 2021, an estimated $3.77M.
  • Marshall Wace Asia first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and held it in 1 quarter.
  • Marshall Wace Asia's NovaBridge Biosciences American Depositary Shares position peaked at $3.77M in Q2 2021.
  • 144 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2021.

Based on Marshall Wace Asia's 13F filing for Q3 2021, filed 15 Nov 2021.